Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice

Archives of Surgery

Volumn 133, Issue 9, 1998, Pages 1002-1006

  Abbott, Robert E ^a   Corral, Claudio J ^a   MacIvor, Debra Marie ^b   Lin, Xuanhan ^a   Ley, Timothy J ^b   Mustoe, Thomas A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; INFLAMMATION; MORPHOMETRICS; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SKIN INCISION; WOUND HEALING;

ANIMALS; CATHEPSINS; INFLAMMATION; MICE; NEUTROPHILS; PEROXIDASE; SERINE ENDOPEPTIDASES; WOUND HEALING;

EID: 0031716089     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.9.1002     Document Type: Article

References (31)

1. Elsbach P, Weiss J. Oxygen-independent antimicrobial systems of phagocytosis. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York, NY: Raven Press; 1992:603-636.
2. Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York, NY: Raven Press; 1992:541-601.
3. Simpson DM, Ross R. The neutrophilic leukocyte in wound repair: a study with antineutrophil serum. J Clin Invest. 1972;51:2009-2023.
4. Leibovich SJ, Ross R. The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975;78:71-100.
5. Hunt TK. Wound Healing and Wound Infection. New York, NY: Appleton-Century-Crofts; 1980.
6. Malech HD, Gallin JI. Neutrophils in human diseases. N Engl J Med. 1988;37: 687-694.
7. Bainton DF, Ullyot JL, Farquhar MG. The development of polymorphonuclear neutrophilic leukocytes in the human bone marrow. J Exp Med. 1971;134: 907-934.
8. Owen CA, Campbell MA, Sannes PL, et al. A surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol. 1995;131:775-789.
9. Selak MA, Chignard M, Smith JB. Cathepsin G is a strong platelet agonist released by neutrophils. J Biochem (Tokyo). 1988;251:293-299.
10. Shafer WM, Polh J, Onunka VC, et al. Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biochem. 1991;266:112-116.
11. Reily CF, Tewksbury DA, Schechter NM, Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem. 1982; 257:8619-8622.
12. Turkington PT. Cathepsin G: a regulator of human vitamin K dependent clotting factors and inhibitors. Thromb Res. 1992;67:147-155.
13. Scuderi P, Nez PA, Derr ML, et al. Cathepsin G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin. Cell Immunol. 1991;135:299-313.
14. Padrines M, Wolf M, Walz A, Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 1994;352:231-235.
15. Hazuda DJ, Strickler J, Kueppers F, et al. Processing of precursor interleukin-1 beta and inflammatory disease. J Biol Chem. 1990;265:6318-6322.
16. Capodici C, Berg RA. Cathepsin G degrades denatured collagen. Inflammation. 1989;13:137-145.
17. Malemud CJ, Janoff A. Identification of neutral proteases in human neutrophil granules that degrade articular cartilage proteoglycan. Arthritis Rheum. 1975; 18:361-368.
18. Reilly CF, Travis J. The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta. 1980;621:147-157.
19. Vartio T, Seppa H, Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase, and cathepsin G. J Biol Chem. 1981;256:471-477.
20. Mustoe TA, Pierce GF, Thomason A, et al. Accelerated healing of incisional wounds in rats induced by TGF-beta. Science. 1987;237:1333-1336.
21. Trush MA, Egner PA, Kensler TW. Myeloperoxidase as a biomarker of skin irritation and inflammation. Food Chem Toxicol. 1994;32:143-147.
22. Sugawara T, Miyamoto M, Takayama S, Kato M. Separation of neutrophils from blood in human and laboratory animals and comparison of the chemotaxis. J Pharmacol Toxicol Methods. 1995;33:91-100.
23. Hogstrom H. Mechanisms and prevention of decrease in wound margin strength in intestinal anastomosis and laparatomy wounds. Acta Chem Scand. 1987;539: 1-63.
24. Jonsson T, Hogstrom H. Neutrophil-dependent decrease in early wound margin strength. Arch Surg. 1991;126:1423-1426.
25. Van Winkle W Jr. The tensile strength of wounds and factors that influence it. Surg Gynecol Obstet. 1969;129:819-842.
26. Rapala K, Laato M, Niinikoski J, et al. Tumor necrosis factor-alpha inhibits wound healing in the rat. Eur Surg Res. 1991;23:261-268.
27. Regan MC, Kirk SJ, Hurson M, et al. Tumor necrosis factor inhibits in vivo collagen synthesis. Surgery. 1993;113:173-177.
28. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem. 1993;53:288-295.
29. Cooney R, Iocono J, Maish G, et al. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis. J Trauma. 1997;42:415-420.
30. Clark RAF. The Molecular and Cellular Biology of Wound Repair. 2nd ed. New York, NY: Plenum Publishing Corp; 1996:8-9.
31. Savill JS, Wyllie AH, Henson JE, et al. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death leads to its recognition by macrophages. J Clin Invest. 1989;83:865-875.